Bio-Rad Laboratories, Inc. (BIO) - Comprehensive Stock Analysis & Investment Research
Deep dive into Bio-Rad Laboratories, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Bio-Rad Laboratories, Inc. Investment Summary
When evaluating whether Bio-Rad Laboratories, Inc. (BIO) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.
Company Profile
Bio-Rad Laboratories, Inc. (BIO) operates within the Industrial Applications and Services sector, specifically in the Laboratory Analytical Instruments industry. The company employs approximately 8,120 people. With a market capitalization of $8 billion, the company is a mid-cap stock that typically offers a balance between growth potential and established business operations.
Financial Performance Analysis
Our comprehensive financial analysis covers Bio-Rad Laboratories, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...
AI Price Predictions
Get AI-powered 7-day, 30-day and 90-day price forecasts for Bio-Rad Laboratories, Inc. along with confidence scores and detailed analysis...
Investment Considerations
Expert analysis of whether Bio-Rad Laboratories, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...
Corporate Identity
Bio-Rad Laboratories, Inc. (Stock Symbol: BIO) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Laboratory Analytical Instruments industry. The company's shares are publicly traded on the NYSE exchange.
Leadership & Workforce
Detailed information about Bio-Rad Laboratories, Inc.'s leadership team, workforce size, and organizational structure...
Market Classification
Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Bio-Rad Laboratories, Inc....
Sector & Industry Analysis
In-depth sector dynamics and industry context for Bio-Rad Laboratories, Inc....
Revenue & Growth Analysis
Bio-Rad Laboratories, Inc. generates annual revenues of $3 billion , indicating a well-established business with proven market demand.
Profitability Metrics
Net profit margin, gross margin, and operating margin analysis for Bio-Rad Laboratories, Inc....
Market Valuation
P/E ratio, price-to-book, and valuation multiples for Bio-Rad Laboratories, Inc....
Return Metrics
Return on equity (ROE), return on assets (ROA), and capital efficiency for Bio-Rad Laboratories, Inc....
Strategic Market Position
Bio-Rad Laboratories, Inc. strategically competes in the highly dynamic Laboratory Analytical Instruments marketplace. As a mid-cap company, it occupies an attractive position balancing growth potential with established operations. Mid-caps often represent the 'sweet spot' for investors seeking companies that have proven their business models but still have meaningful runway for expansion. These companies are large enough to have competitive advantages but nimble enough to adapt quickly to market changes.
Industry Competitive Landscape
Bio-Rad Laboratories, Inc. competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.
Operational Efficiency
The company shows positive operational efficiency through free cash flow generation of $459 million annually , with year-over-year cash flow growth of 25.7%. Positive free cash flow indicates the business generates more cash than required for operations and capital investments, providing resources for growth initiatives or shareholder returns.
Margin & Pricing Power Analysis
The company maintains a 56.8% gross margin indicating healthy pricing power relative to direct production costs. This margin level suggests the company has successfully differentiated its products or services, allowing it to command prices meaningfully above input costs. Maintaining these margins requires ongoing investment in brand, technology, or other differentiating factors.
Operating margin of 18.4% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. This healthy operating margin shows balanced investment in growth functions while maintaining reasonable profitability.
Asset Utilization Efficiency
Asset turnover ratio of 0.20x indicates lower asset turnover that may reflect the industry's capital-intensive nature or potentially underutilized assets. Companies with low turnover typically depend on strong margins to generate adequate returns on capital.
Financial Strength & Leverage
Current ratio of 5.10 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.